Published in Cardiovascular Week, January 30th, 2006
The interim report contains two additional deaths that had occurred within 30 days after treatment with Natrecor but had not been initially reported to the company.
The two new cases were not included in a report on the PROACTION study that was published in the 2005 October issue of the Journal of Emergency...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.